Clinical Trial: Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine
Brief Summary: The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.
Detailed Summary:
Sponsor: National Institute on Drug Abuse (NIDA)
Current Primary Outcome:
- Safety
- Cardiovascular responses
Original Primary Outcome:
- Cocaine craving
- pharmacokinetic assessment
- Safety
- Cardiovascular responses
- Abuse Liability
Current Secondary Outcome:
- Cocaine craving
- pharmacokinetic assessment
- Psychological Effects of Cocaine
- Abuse Liability
- Mood and personality assessments
Original Secondary Outcome:
- Psychological Effects of Cocaine
- Mood and personality assessments
Information By: National Institute on Drug Abuse (NIDA)
Dates:
Date Received: December 13, 2005
Date Started: August 2005
Date Completion:
Last Updated: January 11, 2017
Last Verified: August 2016